Roche shares drop as oral breast cancer drug trial misses goal

Roche's shares dropped more than 5% on Monday as the ​Swiss drugmaker failed to show that its promising breast cancer drug ...

Roche shares drop as oral breast cancer drug fails trial

FRANKFURT, March 9 (Reuters) - Roche's shares dropped more than 5% on Monday as the Swiss drugmaker failed to show that its ...

Roche shares drop as oral breast cancer drug fails in trial

FRANKFURT, March 9 (Reuters) - Shares in Roche dropped more than 5% on Monday as the Swiss drugmaker failed to show that its ...

Signs and symptoms of oral sex-related throat cancer that can appear decades later

The health condition can cause throat or oropharyngeal cancer in high-risk cases, though many of the symptoms which indicate ...

'I'm a dentist - these are the key mouth cancer warning signs everyone needs to know'

A dentist has highlighted potential warning signs of oral cancer that people may overlook, including symptoms that could ...

Signs of throat cancer caused by oral sex after Michael Douglas shared what he noticed first

The signs and symptoms of throat cancer have been explained, with many unaware of its link to oral sex. Actor Michael Douglas went public with his cancer diagnosis back in 2010, but only revealed that ...

'I'm a dentist - these signs can show you have oral cancer without opening your mouth'

While some oral cancer symptoms are visible by looking at teeth and gums others are noticeable before you open your mouth ...
pharmaphorum

Roche's oral SERD flunks phase 3 breast cancer test

AstraZeneca has also filed an oral SERD, camizestrant, targeting use of the drug in patients with advanced HR-positive breast ...
Fierce Biotech

Roche's oral SERD flunks phase 3 trial in 1st-line breast cancer, raising questions of mechanism's limits

A phase 3 trial of Roche’s giredestrant in first-line breast cancer patients has missed its primary endpoint, tarnishing the record of a drug that hit the mark in adjuvant and second-line settings.

New strategy intercepts pancreatic cancer by eliminating microscopic lesions before they become cancer

A new preclinical study in mice shows that precancerous cells in the pancreas can be eliminated before they have the chance to become tumors. Using an experimental therapy to target microscopic ...

Can The Critters in Your Mouth Cause or Cure Disease?

By Carole Tanzer Miller HealthDay ReporterSATURDAY, March 7, 2026 (HealthDay News) — No matter how much you brush, floss and ...
The Manila Times

Kainova Therapeutics Announces Positive Phase I Results for DT-9081, an Oral EP4 Receptor Antagonist, in Advanced Solid Tumors

Phase I results demonstrate favorable safety, sustained target engagement, and early signs of anti-tumor activityReinforce EP4 receptor antagonism as a validated, high-value strategy to overcome ...